Turn Therapeutics
Update in progressTTRX (NasdaqGM)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryBiotechnology
Turn Therapeutics Inc. is a pharmaceuticals company developing drugs for skin, nails, and eye conditions. Its delivery technology penetrates the skin and nails and supports antibiotic stewardship through acute and chronic wound care products. The company serves healthcare institutions for a range of skin issues, from wounds to dermatoses. Formerly Global Health Solutions, Inc, it changed its name in September 2025. Founded in 2015, based in Westlake Village, California.
Company score
- Sentiment
- 0.41
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.14
- Governance
- 0.11
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.06
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.24
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqGM (NGM)
- LocationUnited States
- CEOMr. Bradley E. Burnam
- Founded2015
- Employees2
- Websiteturntherapeutics.com
Identifiers
- ISINUS90021W1053
- FIGIBBG002QTLH75